Related Experiment Videos
Mechanical circulatory support in postoperative cardiogenic shock.
The Journal of Thoracic and Cardiovascular Surgery
|January 1, 1978
Summary
A patient with cardiogenic shock after mitral valve replacement received circulatory support from a left ventricular assist device (LVAS). While the LVAS showed promise for reversible myocardial failure, the patient ultimately succumbed to other medical issues.
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Medical Devices
Background:
- Cardiogenic shock post-mitral valve replacement presents a critical challenge.
- Standard treatments like pressor drugs and intra-aortic balloon pumps can be insufficient.
Observation:
- A 38-year-old woman experienced cardiogenic shock after mitral valve replacement.
- She was unresponsive to conventional therapies, necessitating advanced support.
Findings:
- A left ventricular assist device (LVAS) was implanted for circulatory support.
- The LVAS provided support for 8 days, showing improvement in native cardiac function without device-related complications.
Implications:
- This case suggests the potential utility of LVAS in managing acute, severe, and potentially reversible myocardial failure.
- Further research into LVAS for cardiogenic shock post-cardiac surgery is warranted.